Connect with us

Technology

Hyundai Motor Group Metaplant America Celebrates Grand Opening, Powering U.S. Economic Growth

Published

on

Hyundai Motor Group Metaplant America, the key pillar of the Group’s $12.6 billion investment in Georgia and the largest economic development project in the state’s history, is now openVehicle assembly and battery plant will produce up to 500,000 electric and hybrid vehicles annually for Hyundai, Kia and Genesis brandsHyundai Motor Group commits to an additional $21 billion investment from 2025 to 2028 to drive U.S. manufacturing growthSince entering the U.S., Hyundai Motor Group has invested $20.5 billion in the U.S., creating directly and indirectly more than 570,000 American jobs

ELLABELL, Ga., March 26, 2025 /PRNewswire/ — Hyundai Motor Group Metaplant America (HMGMA) today hosted its Grand Opening celebration, as part of Hyundai Motor Group’s commitment to and investment in the U.S. The ceremony marks the completion of the largest economic development project in Georgia’s history, just two and a half years after breaking ground.

“Hyundai Motor Group Metaplant America not only represents the Group’s advanced manufacturing capabilities and commitment to innovation, but also our investment in relationships with our partners and communities right here in Georgia,” said Euisun Chung, Executive Chair of Hyundai Motor Group. “With the rich history of craftsmanship and manufacturing in this community, together with the talented workforce at HMGMA we are building the future of mobility with America, in America.”

The event was attended by Hyundai Motor Group Executive Chair Chung, Governor Brian P. Kemp, U.S. Representative Buddy Carter, Hyundai Motor Group Vice Chair Jaehoon Chang, Hyundai Motor Company President and CEO José Muñoz, Kia Corporation President and CEO Ho Sung Song, company officials, state and local leaders, HMGMA Meta Pro employees, and other distinguished guests.

“Hyundai Motor Group Metaplant America is a once-in-a-generation opportunity, made possible by our commitment to working with job creators to build fruitful partnerships for decades. Collaborations between HMGMA and Georgia’s universities and technical colleges, including Georgia Quick Start’s on-site training facility, are preparing Georgians for high-quality jobs of today and tomorrow, while our award-winning infrastructure, such as our ports connects companies to markets around the nation and globe,” said Governor Kemp during the event, highlighting the positive impact of the plant on the state’s economy as well as its role in advancing innovative manufacturing and cultivating a skilled labor pool in Georgia.

HMG entered into a landmark agreement with the State of Georgia in May 2022 to establish a cutting-edge electric and hybrid vehicle production and battery manufacturing facility in Ellabell, Georgia, located 20 miles outside of historic Savannah. By June 2022, HMGMA was officially formed, and within four months, the company broke ground on the project, setting an unprecedented pace for development.

On October 3, 2024, less than two years after breaking ground, the first vehicle – a Hyundai IONIQ 5 – rolled off the assembly line, marking a new era for the Group’s U.S. operations. Hyundai’s IONIQ 9 three-row electric SUV is also now in production at HMGMA and will be joined in 2026 by the first Kia model to be built at the facility.

In addition to manufacturing electric vehicles for Hyundai, Genesis, and Kia, the plant is also equipped to produce hybrid vehicles. HMGMA has the capacity to initially produce 300,000 vehicles annually.

Investment and Economic Impact
The Group’s investment in Georgia related to HMGMA and joint battery ventures with LG Energy Solution and SK On is $12.6 billion. This represents the largest single investment in the state’s history and includes a total of 8,500 jobs at HMGMA by 2031. The Group’s total investments in Georgia are expected to create nearly 40,000 direct and indirect jobs, and $4.6 billion in individual earnings every year, according to the Center for Automotive Research.

As of the end of 2024, more than $2.5 billion in capital investment and approximately 6,900 jobs have been announced by HMGMA suppliers in 12 counties across the state. This more than doubles the additional $1 billion investment by suppliers that was originally anticipated.

HMGMA exemplifies the Group’s dedication to fostering economic growth, driving technological advancements, and delivering sustainable solutions to the U.S. market. To date, the Group has invested more than $20.5 billion in the U.S. in the service of these goals, creating or supporting over 570,000 jobs nationwide. 

Earlier this week, the Group announced a significant investment of $21 billion in the U.S. from 2025 to 2028; $9 billion will be invested to establish an annual production capacity in the U.S. of 1.2 million vehicles. The Group plans to expand HMGMA’s annual production capacity to a total of 500,000 units, an increase of 200,000 units from the original plan. In addition, the Group’s existing U.S. production sites – Hyundai Motor Manufacturing Alabama and Kia Autoland Georgia – will also see improvements in production facilities.

A total of $6 billion will be allocated to enhance the Group’s parts and logistics business, as well as establishing an Electric Arc Furnace-based integrated steel mill in the U.S. through its affiliate, Hyundai Steel, with an annual steel production capacity of 2.7 million tons. The mill will supply high-quality automotive steel plates to HMGMA when commercial steel production begins in 2029.

The Group will invest an additional $6 billion to drive innovation and expand strategic partnerships with U.S. companies in areas including autonomous driving, robotics, artificial intelligence (AI), and advanced air mobility (AAM).

Through this $21 billion commitment to drive U.S. manufacturing growth, the Group anticipates it will create 14,000 new direct full-time jobs in the U.S. by 2028. The overall economic impact is expected to generate more than 100,000 direct and indirect job opportunities across related industries. 

Technology and Design
HMGMA’s architecture blends advanced technology with design elements that reflect Hyundai’s brand identity and the natural beauty of the Savannah area.

HMGMA has integrated a variety of proof-of-concept manufacturing technologies and systems from Hyundai Motor Group Innovation Center Singapore (HMGICS), scaling these to accommodate the larger production volume at the Georgia facility.

For example, all HMGMA’s processes – order collection, procurement, logistics and production – are optimized using AI and real-time data, and cutting-edge robotics and vision systems ensure high-quality vehicle production. These innovative manufacturing systems help create a human-centered work environment with robots assisting human workers, improving efficiency.

HMGMA expands its mixed-model production capability and integrates various robot processes to enhance automation, including automated guided vehicles for an optimized logistics system, Boston Dynamic’s Spot for exterior quality inspection in the weld shop, and parking robots in the assembly shop. Automation in HMGMA’s assembly shop is nearly double that of the Group’s existing facilities.

“It’s a historic moment that our state-of-the-art smart plant is officially open,” said Oscar Kwon, CEO of HMGMA. “It is as important for us to create a comfortable and welcoming work environment for our Metaplant employees, also known as Meta Pros, as it is for us to create an energy-efficient and technologically advanced plant. It is essential for our Meta Pros to be happy, comfortable and safe in their work environment for long-lasting careers at HMGMA.”  

All the work zones, from office to production areas, have been designed to encourage communication and build team collaboration. The designs feature open layouts with ample daylight and indoor landscaping. Production areas, such as those in the assembly building, have team centers with skylights delivering natural light at the center of the building and can be used for employee breaks and meetings. 

The 3,050-foot-long front of the HMGMA building’s exterior is lit in two parallel lines, inspired by a stream, and outlines an area where interstate travelers can view the vehicles as they travel by conveyer from paint to general assembly.  

A solar parking lot located at the front of the site will generate 5.2 megawatts of energy, accounting for roughly five percent of the Metaplant’s total power consumption. The solar panels are installed above 1,878 parking spaces, providing shade for vehicles while simultaneously producing electricity.

A 41-acre ecological park that includes trails, running tracks, sports fields, and picnic areas will feature prominently in front of the Metaplant – all for Meta Pros to enjoy before or after work. Construction of the park is ongoing.

Hydrogen Ecosystem
HMGMA has deployed Hyundai Motor XCIENT heavy-duty hydrogen fuel-cell electric trucks for clean logistics operations. A total of 21 XCIENT trucks are currently in operation, representing more than a third of the Glovis America truck fleet at HMGMA, which transport vehicle parts from suppliers across the region to the 2,906-acre Megasite where HMGMA is located on a daily basis.

This industry-leading initiative represents a significant step forward in HMGMA’s leadership efforts to both reduce its carbon footprint and actively promote sustainable practices in daily logistics operations.

Community Engagement
Working under Hyundai Motor Group’s global vision of shaping a better future for humanity through smart mobility solutions and sustainable innovation, Hyundai Motor has supported several non-profit organizations that have had a positive impact on the community, especially in the areas of education, safety and sustainability. Since 2022, Hyundai and Genesis, along with various social responsibility initiatives and nonprofit organizations, have donated nearly $4.5 million to local organizations in Georgia.

Kia’s Autoland Georgia factory in West Point has provided over $22 million in support of Georgia communities since 2009, including more than $6 million to support educational programs such as the THINC College & Career Academy, and SAE’s “A World in Motion.”

About HMGMA 
Hyundai Motor Group Metaplant America (HMGMA) is Hyundai Motor Group’s first dedicated electrified vehicle mass-production plant located in Bryan County, GA. The new plant boasts a highly connected, automated, and flexible manufacturing system, which organically connects all elements of the EV and hybrid ecosystem to realize customer value. The Georgia facility is an intelligent manufacturing plant. All processes of production—order collection, procurement, logistics and production—are optimized utilizing AI and data. The innovative manufacturing system also helps create a human-centered work environment with robots assisting human workers.

About Hyundai Motor Group
Hyundai Motor Group is a global enterprise that has created a value chain based on mobility, steel, and construction, as well as logistics, finance, IT, and service. With about 250,000 employees worldwide, the Group’s mobility brands include Hyundai, Kia, and Genesis. Armed with creative thinking, cooperative communication and the will to take on any challenges, we strive to create a better future for all. More information about Hyundai Motor Group can be found at: http://www.hyundaimotorgroup.com or Newsroom: Media Hub by Hyundai, Kia Global Media Center (kianewscenter.com), Genesis Media Center.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyundai-motor-group-metaplant-america-celebrates-grand-opening-powering-us-economic-growth-302412605.html

SOURCE Hyundai Motor America

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple

Published

on

By

The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.

AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.

The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.

The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.

The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.

According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.

The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.

Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.

The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.

The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.

What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html

SOURCE HelloNation

Continue Reading

Technology

CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group

Published

on

By

Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.

ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.

Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.

“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”

Key Challenges IT Leaders Face in Regulatory Response

Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:

Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.

Info-Tech’s Framework for Building a Regulatory IT Response Engine

To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:

Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.

Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.

The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.

For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html

SOURCE Info-Tech Research Group

Continue Reading

Technology

Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026

Published

on

By

LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.

The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.

https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw

About Atomera

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html

SOURCE Atomera Incorporated

Continue Reading

Trending